NEW YORK, June 4 - GlaxoSmithKline has sold a major portion of its stake in Affymetrix, shrinking its ownership in the biochip company from 13 percent to 8.7 percent, filings with the Securities and Exchange Commission show.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
The New York Times Magazine examines gender discrimination at the Salk Institute.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.